Medical Devices

Image

North America Medical Foods for Inborn Errors of Metabolism Market – Industry Trends and Forecast to 2030

  • Medical Devices
  • Upcoming Report
  • Feb 2023
  • North America
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

North America Medical Foods for Inborn Errors of Metabolism Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 1035.45 Million
Diagram Market Size (Forecast Year) USD 2752.70 Million
Diagram CAGR %

North America Medical Foods for Inborn Errors of Metabolism Market, By Products (Amino Acid, Glytactin with GMP Amino Acid-Modified Infant Formula With Iron, Low-Calcium/Vitamin D-Free Infant Formula With Iron, Low Protein Food and Others), Age Group (Infants, Weaning, Adolescent, Adults), Diseases (Phenylketonuria (PKU),Maple Syrup Urine Disease (MSUD), Homocystinuria, Methylmalonic Acidemia, Organic Acidurias, Propionic Acidemia, Isovaleric Acidemia, Disorders of Leucine Metabolism, Glutaric Acidemia Type I Renal Disease, Tyrosinemia Types I And II, Urea Cycle Disorders and Others), Forms (Powder, Liquids, Gels and Others) Packaging (Can, Jar, Packets, Bottle and Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Drugs Stores, Online Pharmacies and Others) – Industry Trends and Forecast to 2030.

 

North America Medical Foods for Inborn Errors of Metabolism Market Analysis and Size

In comparison to enzyme-based therapeutic medicines, consumption of nutraceutical supplements and prescribed medical food is increasing. The rising cost of healthcare, as well as consumers' preference for simple and effective disease management remedies, are likely to shift the lineage away from pharmaceuticals and toward medical supplements and nutritional foods. Medical food demand has increased over the previous year due to increased medical food expenditure and the introduction of novel products for new indications.

Data Bridge Market Research analyses that the medical foods for inborn errors of metabolism market value is USD 1035.45 million in 2022, is expected to reach USD 2752.70 million by 2030, at a CAGR of 13.00% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

North America Medical Foods for Inborn Errors of Metabolism Market Scope and Segmentation  

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Products (Amino Acid, Glytactin with GMP Amino Acid-Modified Infant Formula With Iron, Low-Calcium/Vitamin D-Free Infant Formula With Iron, Low Protein Food and Others), Age Group (Infants, Weaning, Adolescent, Adults), Diseases (Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), Homocystinuria, Methylmalonic Acidemia, Organic Acidurias, Propionic Acidemia, Isovaleric Acidemia, Disorders of Leucine Metabolism, Glutaric Acidemia Type I Renal Disease, Tyrosinemia Types I And II, Urea Cycle Disorders and Others), Forms (Powder, Liquids, Gels and Others) Packaging (Can, Jar, Packets, Bottle and Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Drugs Stores, Online Pharmacies and Others)

Countries Covered

U.S., Canada and Mexico in North America

Market Players Covered

Nestlé Health Science (Switzerland), Nutricia (Netherlands), Solace Nutrition (U.S.), Abbott (U.S.), Mead Johnson & Company, LLC. (U.S.), BioMarin Pharmaceutical (U.S.), Ajinomoto Cambrooke, Inc. (U.S.), Poa Pharma (Sweden), PKU-MDmil (U.S.), Dr.Schar AG/SPA Primus Pharmaceuticals, Inc. (Italy), Pristine Organics Pvt. Ltd. (India), APR (U.S.), Ener-G foods, INC (U.S.) and Promin Metabolics (U.K.)

Market Opportunities

  • Rising use of medical foods

Market Definition

Inborn metabolic errors (IEMs) can be successfully treated to modern treatment. Medical foods are Medical foods are created for patients whose ability to consume, digest, absorb or metabolise typical meals or nutrients is limited or compromised, making it impossible to regulate their diets only by dietary changes to the typical diet.

North America Medical Foods for Inborn Errors of Metabolism Market Dynamics

Drivers

  • Rising usage of New-born screening

New-born screening is a well-established medical procedure, a successful preventative public health initiative, and an essential health benefit. To achieve the benefits of neonatal screening, the use of medicinal foods is required. The success of PKU new born screening and the following dietary intervention using medical foods to treat the disease led to screening for other conditions that could be treated. As increased new born screening panels, there was an increase in the variety in conditions examined from state to state.

Opportunities

  • Rising use of medical foods

The market is regulated by authoritative and regulatory food and diet supplement statuses, and medical foods are employed as therapy choices for inborn metabolic abnormalities. Between 85% and 90% of a person's dietary requirements are satisfied by the nutritional therapy for congenital metabolic abnormalities. These supplements are also almost completely side effect free making them safe for people of all ages. Private medical insurance in the US and a few other nations have recently started to provide reimbursement programmes for the use of specific medical meals. As a result, market expansion during the forecast period is anticipated to be driven by increased usage of medical food and nutrient supplements.

Restraints/Challenges

  • Inadequate reimbursement scenario

An inadequate reimbursement scenario is expected to limit the use of medical food and slow the growth of the market during the forecast period.

  • High cost of medical foods

Medical foods are created for people who have difficulty swallowing, digesting, absorbing or metabolising regular foods or nutrients and whose nutritional management cannot be accomplished solely by altering their regular diet. Many health insurance policies in the U.S. do not adequately cover medical foods and without insurance many families cannot afford their high cost.

This medical foods for inborn errors of metabolism market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the medical foods for inborn errors of metabolism market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent developments

  • In 2019, In the Netherlands, Nutricia established a sustainable facility. The large investment in the Nutricia Cuijk facility raised the production of specialised infant formula and the market's income.
  • In 2022, Mead Johnson & Company, LLC announced that it has merged entirely with Reckitt Benckiser Group plc (RB). It was anticipated that the Mead Johnson brand and business would continue to grow to the effective innovation and marketing practises used by Reckitt Benckiser plc businesses.

North America Medical Foods for Inborn Errors of Metabolism Market Scope

The medical foods for inborn errors of metabolism market is segmented on the basis of products, age group, diseases, forms, packaging and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Products

  • Amino Acid
  • Glytactin with GMP Amino Acid-Modified Infant Formula with Iron
  • Low-Calcium/Vitamin D-Free Infant Formula with Iron
  • Low Protein Food
  • Others

 Age Group

  • Infants
  • Weaning
  • Adolescent
  • Adults

 Diseases

  • Phenylketonuria (PKU)
  • Maple Syrup Urine Disease (MSUD)
  • Homocystinuria
  • Methylmalonic Acidemia
  • Organic Acidurias
  • Propionic Acidemia
  • Isovaleric Acidemia
  • Disorders of Leucine Metabolism
  • Glutaric Acidemia Type I Renal Disease
  • Tyrosinemia Types I and II
  • Urea Cycle Disorders
  • Others

 Forms

  • Powder
  • Liquids
  • Gels and Others

 Packaging

  • Can
  • Jar
  • Packets
  • Bottle
  • Others

Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Drugs Stores
  • Online Pharmacies
  • Others

Medical Foods for Inborn Errors of Metabolism Market Regional Analysis/Insights

The medical foods for inborn errors of metabolism market is analysed and market size insights and trends are provided by country, products, age group, diseases, forms, packaging and distribution channel as referenced above.

The countries covered in the medical foods for inborn errors of metabolism market report are U.S., Canada and Mexico in North America

U.S. is dominating in the market with increased awareness about the inborn errors of metabolism and their treatment.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The medical foods for inborn errors of metabolism market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for medical foods for inborn errors of metabolism market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the medical foods for inborn errors of metabolism market. The data is available for historic period 2011-2021.

Competitive Landscape and Medical Foods for Inborn Errors of Metabolism Market Share Analysis

The medical foods for inborn errors of metabolism market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to medical foods for inborn errors of metabolism market.

Some of the major players operating in the medical foods for inborn errors of metabolism market are:

  • Nestlé Health Science (Switzerland)
  • Nutricia (Netherlands)
  • Solace Nutrition (U.S.)
  • Abbott (U.S.)
  • Mead Johnson & Company, LLC. (U.S.)
  • BioMarin Pharmaceutical (U.S.)
  • Ajinomoto Cambrooke, Inc. (U.S.)
  • Poa Pharma (Sweden)
  • PKU-MDmil (U.S.)
  • Dr.Schar AG/SPA Primus Pharmaceuticals, Inc. (Italy)
  • Pristine Organics Pvt. Ltd.(India)
  • APR (U.S.)
  • Ener-G Foods (U.S.)
  • Promin Metabolics (U.K.) 


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The medical foods for inborn errors of metabolism market value was USD 1035.45 million in 2022.
The medical foods for inborn errors of metabolism market is projected to grow at a CAGR of 13.00% during the forecast period of 2023-2030.
It's divided by type, usage, pest type, function, and applications.
U.S. is dominating in the market with increased awareness about the inborn errors of metabolism and their treatment.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials